| Bid Price | 1250.00p | High Price | 1310.00p |
|---|
| Ask Price | 1350.00p | Low Price | 1310.00p |
|---|
| Open Price | 1300.00p | Spread | 7.41% |
|---|
| Prev Close | 1300.00p | Volume | 2 |
|---|
4Basebio PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 20, 2024 | 1300.00 | 1308.00 | 1262.00 | 1300.00 | 201 |
| Nov 19, 2024 | 1300.00 | 1260.00 | 1260.00 | 1300.00 | 61 |
| Nov 18, 2024 | 1325.00 | 1310.00 | 1260.50 | 1300.00 | 1,856 |
| Nov 15, 2024 | 1325.00 | 1325.00 | 1325.00 | 1325.00 | 46,500 |
4Basebio PLC Information
| Name | 4Basebio PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BMCLYF79 | Epic | 4BB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 500 | Trading Status | Closed |
|---|
| Shares in Issue | 12.81 m | Prev Close | 1300.00p |
|---|
| PE Ratio | | Market Cap | £166.54 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.45 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 2.72687 | Quick Ratio | 1.534626 |
|---|
4Basebio PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 19/11/24 | BUY | Heikki Lanckriet | CEO | 93,000 @ £13.25 | £1,232,250.00 |
| 19/11/24 | SELL | Heikki Lanckriet | CEO | 93,000 @ £13.25 | £1,232,250.00 |
| 19/11/24 | BUY | Heikki Lanckriet | CEO | 46,500 @ £13.25 | £616,125.00 |
| 19/11/24 | SELL | Heikki Lanckriet | CEO | 46,500 @ £13.25 | £616,125.00 |
| 21/09/24 | SELL | Heikki Lanckriet | CEO | 315,706 @ £15.00 | £4,735,590.00 |
| 21/09/24 | SELL | David Roth | FD | 101,834 @ £15.00 | £1,527,510.00 |
| 21/09/24 | SELL | Joseph Fernandez | NED | 95,916 @ £15.00 | £1,438,740.00 |
| 21/09/24 | SELL | Amy Walker | ED | 11,459 @ £15.00 | £171,885.00 |
| 05/02/24 | SELL | Heikki Lanckriet | CEO | 45,322 @ £6.60 | £299,125.00 |
| 05/02/24 | SELL | David Roth | FD | 38,292 @ £6.60 | £252,727.00 |
4Basebio PLC News
